Amy Guggenheim Shenkan - Jan 13, 2022 Form 4 Insider Report for ZUORA INC (ZUO)

Role: Director
Signature: /s/ Jennifer Pileggi as attorney-in-fact for Amy Guggenheim Shenkan
Stock symbol: ZUO
Transactions as of: Jan 13, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/18/2022, 04:09 PM
Previous filing: Dec 20, 2021
Next filing: Mar 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZUO	Class A Common Stock	Award	$0	+24.8K		$0.00	24.8K	Jan 13, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects Restricted Stock Units (RSUs) granted on January 13, 2022, upon the appointment of the Reporting Person to the Issuer's Board of Directors. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest and convert into shares of the Issuer's Class A Common Stock as to 1/3rd of the total number of RSUs subject to the award on each of January 13, 2023, January 13, 2024, and January 13, 2025, in each case, so long as the Reporting Person continues to provide services to the Issuer through such date. The vesting of the RSUs shall accelerate in full upon the consummation of a Corporate Transaction, as defined in the Issuer's 2018 Equity Incentive Plan.

Content

Reflects Restricted Stock Units (RSUs) granted on January 13, 2022, upon the appointment of the Reporting Person to the Issuer's Board of Directors. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest and convert into shares of the Issuer's Class A Common Stock as to 1/3rd of the total number of RSUs subject to the award on each of January 13, 2023, January 13, 2024, and January 13, 2025, in each case, so long as the Reporting Person continues to provide services to the Issuer through such date. The vesting of the RSUs shall accelerate in full upon the consummation of a Corporate Transaction, as defined in the Issuer's 2018 Equity Incentive Plan.